Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 3, 2025 Off

Alnylam Pharmaceuticals Announces Changes to Board of Directors

By BusinessWire

– Mike Bonney and Carolyn Bertozzi to Depart; Company Appoints Stuart Arbuckle as New Independent Director – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam…

December 3, 2025 Off

ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma

By BusinessWire

Prospective, randomized controlled trial compares novel femtosecond laser procedure to selective laser trabeculoplasty (SLT), advancing path to US commercialization ALISO…

December 3, 2025 Off

Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition

By BusinessWire

Company to highlight progress over the past year with existing and potential customers. SCHAUMBURG, Ill.–(BUSINESS WIRE)–Avenacy, a specialty pharmaceutical company…

December 3, 2025 Off

Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing

By BusinessWire

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President: Toshiaki Nagasato) today announced a strategic equity investment in…

December 3, 2025 Off

TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline

By BusinessWire

Financing co-led by new investors, Ascenta Capital and Bessemer Venture Partners Additional new investors included YK Bioventures, Regeneron Ventures, Invus,…

December 3, 2025 Off

Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do

By BusinessWire

Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical…

December 3, 2025 Off

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

By BusinessWire

Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies CONSHOHOCKEN,…

December 3, 2025 Off

Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease

By BusinessWire

Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring Committee BMS Remains Blinded to Study Data…

December 3, 2025 Off

Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocarcinoma1

By BusinessWire

Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK2 BAAR, Switzerland–(BUSINESS WIRE)–For United Kingdom (UK)…

December 3, 2025 Off

Clene to Provide CNM-Au8® ALS Program Update

By GlobeNewswire

Webcast set for 8:30 a.m. ET on December 3rdSALT LAKE CITY, Dec. 02, 2025 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq:…

Posts pagination

Previous 1 … 6 7 8 … 6,180 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

December 5, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine